Hyaluronic acid inhibits mRNA expression of proinflammatory cytokines and cyclooxygenase-2/prostaglandin E2 production via CD44 in lnterleukin-1- stimulated subacromial synovial fibroblasts from patients with rotator cuff disease

Journal of Orthopaedic Research

Volumn 26, Issue 7, 2008, Pages 1032-1037

  Mitsui, Yasuhiro ^a   Gotoh, Masafuml ^b   Nakama, Kenjirou ^b   Yamada, Tetsu ^a   Higuchi, Fujio ^b   Nagata, Kensei ^a  

^a KURUME UNIVERSITY   (Japan)

^b KURUME UNIVERSITY MEDICAL CENTER   (Japan)

Author keywords

Cyclooxygenase 2; Hyaluronic acid; Proinflammatory cytokines; Prostaglandin E2; Rotator cuff disease

Indexed keywords

ANTIBODY; CYCLOOXYGENASE 2; CYTOKINE; HERMES ANTIGEN; HYALURONIC ACID; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; IMMUNOLOGICAL ADJUVANT; PTGS2 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; DRUG BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ROTATOR CUFF INJURY; WESTERN BLOTTING; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; ROTATOR CUFF; SECRETION; SYNOVITIS;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIGENS, CD44; CELLS, CULTURED; CYCLOOXYGENASE 2; CYTOKINES; DINOPROSTONE; FIBROBLASTS; HUMANS; HYALURONIC ACID; INTERLEUKIN-1; MIDDLE AGED; RNA, MESSENGER; ROTATOR CUFF; SYNOVITIS;

EID: 46449129471     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20558     Document Type: Article

References (32)

1. Gotoh M, Hamada K, Yamakawa H, et al. 1998. Increased substance P in subacromial bursa and shoulder pain in rotator cuff diseases. J Orthop Res 16:618-621.
2. Ide K, Shirai Y, Ito H, et al. 1996. Sensory nerve supply in the human subacromial bursa. J Shoulder Elbow Surg 5:371-382.
3. Soifer TB, Levy HJ, Soifer FM, et al. 1996. Neurohistology of the subacromial space. Arthroscopy 12:182-186.
4. McCormack R. 2006. Effectiveness of a single corticosteroid injection for chronic rotator cuff tendinosis. Clin J Sport Med 16:88-89.
5. Alvarez CM, Litchfield R, Jackowski D, et al. 2005. A prospective, double-blind, randomized clinical trial comparing subacromial injection of betamethasone and xylocaine to xylocaine alone in chronic rotator cuff tendinosis. Am J Sports Med 33:255-262.
6. Valtonen EJ. 1978. Double acting betamethasone (Celestone Chronodose) in the treatment of supraspinatus tendinitis: a comparison of subacromial and gluteal single injections with placebo. J Int Med Res 6:463-467.
7. Santavirta S, Konttinen YT, Antti-Poika I, et al. 1992. Inflammation of the subacromial bursa in chronic shoulder pain. Arch Orthop Trauma Surg 111:336-340.
8. Blaine TA, Kim YS, Voloshin I, et al. 2005. The molecular pathophysiology of subacromial bursitis in rotator cuff disease. J Shoulder Elbow Surg 14:84S-89S.
9. Voloshin I, Gelinas J, Maloney MD, et al. 2005. Proinflammatory cytokines and metalloproteases are expressed in the subacromial bursa in patients with rotator cuff disease. Arthroscopy 21:1076.
10. Gotoh M, Hamada K, Yamakawa H, et al. 2001. Interleukin-1-induced subacromial synovitis and shoulder pain in rotator cuff disease. Rheumatology (Oxford) 40:995-1001.
11. Wang CT, Lin YT, Chiang BL, et al. 2006. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage 14:1237-1247.
12. Brandt KD, Block JA, Michalski JP, et al. 2001. Efficacy and safety of intraarticular sodium hyaluronate in knee osteoarthritis. ORTHOVISC Study Group. Clin Orthop Relat Res 385:130-143.
13. Adams ME, Lussier AJ, Peyron JG. 2000. A risk-benefit assessment of injections of hyaluronan and its derivatives in the treatment of osteoarthritis of the knee. Drug Saf 23:115-130.
14. Lohmander LS, Dalen N, Englund G, et al. 1996. Intraarticular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 55:424-431.
15. Shibata Y, Midorikawa K, Emoto G, et al. 2001. Clinical evaluation of sodium hyaluronate for the treatment of patients with rotator cuff tear. J Shoulder Elbow Surg 10:209-216.
16. Shimizu Y, Van Seventer GA, Siraganian R, et al. 1989. Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143:2457-2463.
17. Miyake K, Medina KL, Hayashi S, et al. 1990. Monoclonal antibodies to Pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171:477-488.
18. Jalkanen S, Bargatze RF, de los Toyos J, et al. 1987. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells. J Cell Biol 105:983-990.
19. Gunthert U, Hofmann M, Rudy W, et al. 1991. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24.
20. Galea-Lauri J, Wilkinson JM, Evans CH. 1993. Characterization of monoclonal antibodies against rabbit C D44:evidence of a role for CD44 in modulating synoviocyte metabolism. Mol Immunol 30:1383-1392.
21. Jimbo K, Park JS, Yokosuka K, et al. 2005. Positive feedback loop of interleukin-1beta upregulating production of inflammatory mediators in human intervertebral disc cells in vitro. J Neurosurg Spine 2:589-595.
22. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
23. Underhill C. 1992. C D44:the hyaluronan receptor. J Cell Sci 103:293-298.
24. Shimizu M, Yasuda T, Nakagawa T, et al. 2003. Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 30:1164-1172.
25. Gilroy DW, Tomlinson A, Willoughby DA. 1998. Differential effects of inhibition of isoforms of cyclooxygenase (COX-1, COX-2) in chronic inflammation. Inflamm Res 47:79-85.
26. Lipsky PE. 1999. Role of cyclooxygenase-1 and -2 in health and disease. Am J Orthop 28:8-12.
27. Narumiya S, Sugimoto Y, Ushikubi F. 1999. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226.
28. O'Neill LA, Barrett ML, Lewis GP. 1987. Induction of cyclooxygenase by interleukin-1 in rheumatoid synovial cells. FEBS Lett 212:35-39.
29. Noble PW. 2002. Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21:25-29.
30. Leardini G, Perbellini A, Franceschini M, et al. 1988. Intraarticular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 10:521-526.
31. Itokazu M, Matsunaga T. 1995. Clinical evaluation of high-molecular- weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 17:946-955.
32. Rovetta G, Monteforte P. 1998. Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue React 20:125-130.